Fungal infections are on the rise globally. According to a study by the Manchester Fungal Infection Group, in 2022, ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top ...

BMO Capital Markets analysts said the results potentially position lepodisiran as “one of the most durable assets in ...

Bioluminescent luciferase enzymes have historically been too dim to use as probes in living tissue. But recent advances have ...

When exposed to antibiotics, approximately one out of every 10 8 -10 9 bacteria develops resistance due to spontaneous ...

A single dose of an experimental drug has been found to reduce the risk of genetic heart disease by at least 94 per cent. Lepodisiran, developed by Eli Lilly, has shown promising results in reducing ...

Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger ...

Quantbot Technologies LP acquired a new position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the ...

Large-scale data on the hepatitis D virus (HDV)/hepatitis B virus (HBV) co-infection rate is needed to estimate the current ...